Merchant
Capital
Our team is well positioned to leverage our global resources and match emerging growth companies with high-quality financial and strategic investors. Our skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences / biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
Using our distribution capabilities, we target a specific group of investors and organize meetings that can maximize management’s time. In our experience, an orchestrated process helps to streamline the transaction and thereby its competitiveness. A key to our success is aligning ourselves with top investors, strategic thinkers, entrepreneurs and executives around the world.
Completed
Transactions
Merchant
Capital Team
Latest Maxim Group News
INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market
INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on
Intchains Group Limited Announces Pricing of US$8.0 Million Initial Public Offering
Intchains Group Limited (the “Company” or “Intchains Group”), a provider of integrated solutions consisting of
SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement
SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company